+ ...

One of the numerous suits challenging the retention of American Century target-date funds has won its motion to dismiss.

Enlicitide, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions Compared to Oral Non ...

India, March 30 -- E-cigarettes with nicotine may be the most effective tool for quitting smoking. They appear to outperform traditional nicotine replacement therapies such as patches, gum, and ...

But the reliability of these billion-transistor systems often depends on a much simpler and frequently overlooked block: the Reset Controller. An SoC is only as reliable as its ability to power up ...

Positive topline results from the phase 3 GLOW2 trial suggest that tarcocimab tedromer (Zenkuda), an investigational anti–vascular endothelial growth factor (VEGF) biologic, may offer durable disease ...

AbbVie’s Skyrizi appears to have stronger efficacy than Johnson & Johnson’s newly approved pill Icotyde, as well as a less frequent dosing schedule that patients could prefer, according to analysts at ...

Childhood obesity increases cardiometabolic risk even in “healthy” cases. Early treatment may reduce long-term disease burden. Find out more.

Medicare Part D’s 2024 redesign—catastrophic coinsurance removal and expanded full LIS eligibility—was associated with a ...

Missing one of its co-primary endpoints could make it difficult for Karyopharm Therapeutics to score conventional approval ...